Search results
Foodborne trematodiases
Schistosomiasis
Well-being in the US
A new analysis reveals stark disparities within the United States and highlights the urgency of tackling deeply rooted structural inequalities through social programs.
Disparities in wellbeing in the USA by race and ethnicity, age, sex, and location, 2008–21: an analysis using the Human Development Index
Years of education, household consumption, and expected lifespan—and thus the Human Development Index—varied considerably among adults in the USA during the 2008–21 period.
WHO Rehabilitation Need Estimator
Analyze estimates of the world’s need for rehabilitation services from 1990 to 2021.
Human African trypanosomiasis
Malaria
Global, regional, and national stillbirths at 20 weeks’ gestation or longer in 204 countries and territories, 1990–2021
In 2021, the global stillbirth rate was 23 per 1000 births at 20 weeks’ gestation or longer, compared to 16 per 1000 births at 28 weeks’ gestation or longer.
Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021
Pulmonary arterial hypertension (PAH) is a vascular disease characterised by restricted flow and high pressure through the pulmonary arteries, leading to progressive right heart failure and death.
Prevalence of glaucoma among US adults in 2022
We estimated that 4.22 million people in the US (1.62% of adults) had glaucoma and 1.49 million people (0.57% of adults) had vision-affecting glaucoma in 2022.
2024 Roux Prize Recipient: Dr. Madeleine Ballard
On behalf of the Community Health Impact Coalition (CHIC), Dr. Madeleine Ballard, global health leader and CEO of CHIC, is the Institute for Health Metrics and Evaluation’s 2024 Roux Prize winner.
Persistent DNA methylation changes across the first year of life and prenatal NO2 exposure in a Canadian prospective birth study
Evidence suggests that prenatal air pollution exposure alters DNA methylation (DNAm), which could go on to affect long-term health.
GBD Tobacco Forecasts
Explore patterns in future smoking scenarios from 2022 to 2050.
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050
Smoking is the leading behavioural risk factor for mortality globally, accounting for more than 175 million deaths and nearly 4·30 billion years of life lost (YLLs) from 1990 to 2021.
Antibiotic-resistant infections are increasing quickly, made worse by inequalities
By 2050, deaths from antibiotic-resistant infections could rise by roughly two-thirds unless the world intervenes.
Global, regional, and national burden of stroke and its risk factors, 1990–2021
Up-to-date estimates of stroke burden and attributable risks and their trends at global, regional, and national levels are essential for evidence-based health care, prevention, and resource allocation planning.
MICROBE
The MICROBE (Measuring Infectious Causes and Resistance Outcomes for Burden Estimation) tool visualizes the fatal and nonfatal health outcomes of infections, pathogens, and antimicrobial resistance across different countries and regions.
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
In 2021, we estimated 4.71 million deaths were associated with bacterial AMR, including 1.14 million deaths attributable to bacterial AMR.
Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021
Upper respiratory infections (URIs) are the leading cause of acute disease incidence worldwide and contribute to a substantial health care burden.
The burden of liver cancer in Mongolia from 1990-2019
Liver cancer remains the leading cause of death and public health threat among the Mongolian population.
Financing health in sub-Saharan Africa 1990– 2050: Donor dependence and expected domestic health spending
Development assistance for health provided to sub-Saharan Africa is expected to decrease in some countries, and the expected growth in government health spending might not be enough to cover this expected decline.